Study of an oral drug for healthy and overweight adults
Part of Hormones & metabolism clinical trials.
This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 55 years old.
- Be generally healthy (no major medical conditions, such as heart, liver, kidney, or pancreatic disease).
- Have a BMI within specific ranges (19-28 for the single-dose part; 24-35 for the multiple-dose part).
- Agree to use reliable birth control during the study and for 3 months after the last dose.
- Avoid taking any medications (including over-the-counter, herbal, or weight-loss drugs) for at least 2 weeks before the study (and for GLP-1 drugs, 6 months).
- Have no history of drug or alcohol abuse, and be willing to follow dietary restrictions (e.g., avoid caffeine, grapefruit, alcohol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.
This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.
This trial tests a new medicine, CG-0416, in healthy people to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
This early-stage trial tests how safe and tolerable CMS-D008, an experimental weight-management medicine, is in healthy adults who are overweight or obese. Researchers will gradually increase the dose to find the right amount and monitor how your body responds.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
Hear when a new Healthy Subjects;Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.